Mariner’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98M Buy
78,363
+1,406
+2% +$35.9K ﹤0.01% 1529
2025
Q4
$1.96M Buy
76,957
+1,160
+2% +$29.7K ﹤0.01% 1515
2025
Q3
$1.94M Buy
75,797
+5,691
+8% +$144K ﹤0.01% 1461
2025
Q2
$1.77M Buy
70,106
+4,546
+7% +$113K ﹤0.01% 1418
2025
Q1
$1.64M Buy
65,560
+2,953
+5% +$73K ﹤0.01% 1349
2024
Q4
$1.54M Buy
62,607
+3,109
+5% +$77.8K ﹤0.01% 1362
2024
Q3
$1.53M Buy
59,498
+792
+1% +$20K ﹤0.01% 1339
2024
Q2
$1.44M Buy
58,706
+10,445
+22% +$255K ﹤0.01% 1284
2024
Q1
$1.2M Buy
48,261
+30,783
+176% +$763K ﹤0.01% 1395
2023
Q4
$441K Buy
+17,478
New +$417K ﹤0.01% 2030

Other funds holding IBDX

Mariner's IBDX Position: Q1 2026 in Review

Mariner increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 1.8% in Q1 2026, buying an estimated $35.9K and bringing the position to 78,363 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Mariner first reported a position in IBDX in Q4 2023 and has held it in 10 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Mariner held 78,363 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.98M as of Q1 2026.
  • Mariner bought 1,406 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $35.9K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #1529 holding.
  • Mariner first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.